Drug Shortage Report for RIVA-OLMESARTAN
Report ID | 55204 |
Drug Identification Number | 02471353 |
Brand name | RIVA-OLMESARTAN |
Common or Proper name | Riva-Olmesartan 20mg |
Company Name | LABORATOIRE RIVA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OLMESARTAN MEDOXOMIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 / 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2018-07-10 |
Actual start date | 2018-07-10 |
Estimated end date | Unknown |
Actual end date | 2019-04-17 |
Shortage status | Resolved |
Updated date | 2019-04-18 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-07-10 | English | Compare |
v2 | 2018-07-10 | English | Compare |
v3 | 2018-07-10 | French | Compare |
v4 | 2018-07-10 | English | Compare |
v5 | 2018-07-10 | French | Compare |
v6 | 2018-07-11 | English | Compare |
v7 | 2019-04-17 | English | Compare |
v8 | 2019-04-17 | French | Compare |
v9 | 2019-04-18 | English | Compare |
Showing 1 to 9 of 9